The continuing challenge of understanding, preventing, and treating neural tube defects

Science

Volumn 339, Issue 6123, 2013, Pages

  Wallingford, John B ^a   Niswander, Lee A ^b   Shaw, Gary M ^c   Finnell, Richard H ^d  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Children's Hospital Colorado   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

BIRTH RATE; DEVELOPMENTAL BIOLOGY; DISEASE CONTROL; ESTIMATION METHOD; ETIOLOGY; GENETIC ANALYSIS; NEONATE; NERVOUS SYSTEM; NUMERICAL MODEL; PUBLIC HEALTH;

BODY BURDEN; CELL POLARITY; CYTOLOGY; EMBRYO DEVELOPMENT; EMBRYOLOGY; EPIGENETICS; EUKARYOTIC FLAGELLUM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; MOLECULAR GENETICS; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE; NEURAL TUBE DEFECT; NONHUMAN; PLANAR CELL POLARITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

UNITED STATES;

EID: 84874365790     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1222002     Document Type: Review

References (102)

1. H. J. Blom, G. M. Shaw, M. den Heijer, R. H. Finnell, Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 7, 724 (2006). doi: 10.1038/nrn1986; pmid: 16924261
2. N. S. Adzick et al., A randomized trial of prenatal versus postnatal repair of myelomeningocele. N. Engl. J. Med. 364, 993 (2011). doi: 10.1056/NEJMoa1014379; pmid: 21306277
3. Z. Li et al., Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res. A Clin. Mol. Teratol. 76, 237 (2006). doi: 10.1002/bdra.20248; pmid: 16575897
4. E. E. Castilla, I. M. Orioli, J. S. Lopez-Camelo, M. G. Dutra, J. Nazer-Herrera, Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am. J. Med. Genet. A 123A, 123 (2003). doi: 10.1002/ajmg.a.20230; pmid: 14598335
5. Y. Yamaguchi, M. Miura, How to form and close the brain: Insight into the mechanism of cranial neural tube closure in mammals. Cell. Mol. Life Sci. (2012). doi: 10.1007/s00018-012-1227-7; pmid: 23242429
6. A. J. Copp, N. D. E. Greene, Genetics and development of neural tube defects. J. Pathol. 220, 217 (2010). pmid: 19918803
7. J. B. Wallingford, Neural tube closure and neural tube defects: Studies in animal models reveal known knowns and known unknowns. Am. J. Med. Genet. 135C, 59 (2005). doi: 10.1002/ajmg.c.30054; pmid: 15806594
8. J. F. Colas, G. C. Schoenwolf, Towards a cellular and molecular understanding of neurulation. Dev. Dyn. 221, 117 (2001). doi: 10.1002/dvdy.1144; pmid: 11376482
9. Centers for Disease Control and Prevention (CDC), Neural tube defect surveillance and folic acid intervention - Texas-Mexico border, 1993-1998. MMWR Morb. Mortal. Wkly. Rep. 49, 1 (2000). pmid: 10993565
10. K. L. Deak et al., Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 82, 662 (2008). doi: 10.1002/bdra.20511; pmid: 18937341
11. J. L. Hall, M. J. Harris, D. M. Juriloff, Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice. Teratology 55, 306 (1997). doi: 10.1002/(SICI)1096-9926(199705)55: 5〈306::AID-TERA2〉3.0.CO;2-X; pmid: 9261924
12. K. S. Au, A. Ashley-Koch, H. Northrup, Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev. Disabil. Res. Rev. 16, 6 (2010). doi: 10.1002/ddrr.93; pmid: 20419766
13. G. M. Shaw et al., 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med. Genet. 10, 49 (2009). doi: 10.1186/1471-2350-10-49; pmid: 19493349
14. A. M. Molloy, L. C. Brody, J. L. Mills, J. M. Scott, P. N. Kirke, The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 85, 285 (2009). doi: 10.1002/bdra.20566; pmid: 19235830
15. A. F. Olshan, G. M. Shaw, R. C. Millikan, C. Laurent, R. H. Finnell, Polymorphisms in DNA repair genes as risk factors for spina bifida and orofacial clefts. Am. J. Med. Genet. A 135A, 268 (2005). doi: 10.1002/ajmg.a.30713; pmid: 15887293
16. P. X. Tran et al., Association of retinoic acid receptor genes with meningomyelocele. Birth Defects Res. A Clin. Mol. Teratol. 91, 39 (2011). doi: 10.1002/bdra.20744; pmid: 21254357
17. D. M. Juriloff, M. J. Harris, A consideration of the evidence that genetic defects in planar cell polarity contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 94, 824 (2012). doi: 10.1002/bdra.23079; pmid: 23024041
18. S. G. Obican, R. H. Finnell, J. L. Mills, G. M. Shaw, A. R. Scialli, Folic acid in early pregnancy: A public health success story. FASEB J. 24, 4167 (2010). doi: 10.1096/fj.10-165084; pmid: 20631328
19. J. S. Sheffield, E. L. Butler-Koster, B. M. Casey, D. D. McIntire, K. J. Leveno, Maternal diabetes mellitus and infant malformations. Obstet. Gynecol. 100, 925 (2002). doi: 10.1016/S0029-7844(02)02242-1; pmid: 12423854
20. G. M. Shaw, E. M. Velie, D. Schaffer, Risk of neural tube defect-affected pregnancies among obese women. JAMA 275, 1093 (1996). doi: 10.1001/jama.1996. 03530380035028; pmid: 8601928
21. E. J. Lammer, L. E. Sever, G. P. Oakley Jr., Valproic acid. Teratology 35, 465 (1987). doi: 10.1002/tera.1420350319; pmid: 3114906
22. L. McLeod, J. G. Ray, Prevention and detection of diabetic embryopathy. Community Genet. 5, 33 (2002). doi: 10.1159/000064629; pmid: 14960898
23. J. G. Ray, T. E. O'Brien, W. S. Chan, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM 94, 435 (2001). doi: 10.1093/qjmed/94.8.435; pmid: 11493721
24. G. M. Shaw et al., Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am. J. Clin. Nutr. 78, 972 (2003). pmid: 14594784
25. D. K. Waller et al., Are obese women at higher risk for producing malformed offspring? Am. J. Obstet. Gynecol. 170, 541 (1994). pmid: 8116710
26. M. M. Werler, C. Louik, S. Shapiro, A. A. Mitchell, Prepregnant weight in relation to risk of neural tube defects. JAMA 275, 1089 (1996). doi: 10.1001/jama.1996.03530380031027; pmid: 8601927
27. K. A. Hendricks, O. M. Nuno, L. Suarez, R. Larsen, Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 12, 630 (2001). doi: 10.1097/00001648-200111000-00009; pmid: 11679789
28. K. J. Meador et al., In utero antiepileptic drug exposure: Fetal death and malformations. Neurology 67, 407 (2006). doi: 10.1212/01.wnl.0000227919. 81208.b2; pmid: 16894099
29. H. Kanai, A. Sawa, R.-W. Chen, P. Leeds, D.-M. Chuang, Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J. 4, 336 (2004). doi: 10.1038/sj.tpj.6500269; pmid: 15289798
30. E. Yildirim et al., Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci. Lett. 345, 141 (2003). doi: 10.1016/S0304-3940(03)00490-7; pmid: 12821190
31. N. D. Greene, P. Stanier, G. E. Moore, The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics 6, 875 (2011). doi: 10.4161/epi.6.7.16400; pmid: 21613818
32. W. Lin et al., Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev. Dyn. 237, 928 (2008). doi: 10.1002/dvdy.21479; pmid: 18330926
33. J. P. M. Barbera et al., Folic acid prevents exencephaly in Cited2 deficient mice. Hum. Mol. Genet. 11, 283 (2002). doi: 10.1093/hmg/11.3.283; pmid: 11823447
34. C. J. Phiel et al., Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734 (2001). doi: 10.1074/jbc.M101287200; pmid: 11473107
35. A. Drugan, A. Weissman, M. I. Evans, Screening for neural tube defects. Clin. Perinatol. 28, 279, vii (2001). doi: 10.1016/S0095-5108(05)70083-X; pmid: 11499052
36. R. M. Bowman, D. G. McLone, J. A. Grant, T. Tomita, J. A. Ito, Spina bifida outcome: A 25-year prospective. Pediatr. Neurosurg. 34, 114 (2001). doi: 10.1159/000056005; pmid: 11359098
37. N. S. Adzick, Fetal surgery for myelomeningocele: trials and tribulations. J. Pediatr. Surg. 47, 273 (2012). doi: 10.1016/j.jpedsurg.2011.11. 021; pmid: 22325376
38. M. Dennis, M. A. Barnes, The cognitive phenotype of spina bifida meningomyelocele. Dev Disabil Res Rev 16, 31 (2010). doi: 10.1002/ddrr.89; pmid: 20419769
39. MRC Vitamin Study Research Group, Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338, 131 (1991). doi: 10.1016/0140-6736(91)90133-A; pmid: 1677062
40. R. J. Berry et al., Prevention of neural-tube defects with folic acid in China. China-U.S. N. Engl. J. Med. 341, 1485 (1999). doi: 10.1056/ NEJM199911113412001; pmid: 10559448
41. M. A. Canfield et al., Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: Findings from a multi-state population-based study. Birth Defects Res. A Clin. Mol. Teratol. 73, 679 (2005). doi: 10.1002/bdra.20210; pmid: 16240378
42. M. A. Honein, L. J. Paulozzi, T. J. Mathews, J. D. Erickson, L. Y. Wong, Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285, 2981 (2001). doi: 10.1001/jama.285.23.2981; pmid: 11410096
43. L. J. Williams et al., Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66, 33 (2002). doi: 10.1002/tera.10060; pmid: 12115778
44. P. De Wals et al., Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 357, 135 (2007). doi: 10.1056/NEJMoa067103; pmid: 17625125
45. J. S. López-Camelo et al., Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am. J. Med. Genet. A 135A, 120 (2005). doi: 10.1002/ajmg.a.30651; pmid: 15846825
46. J. A. Piedrahita et al., Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23, 228 (1999). doi: 10.1038/13861; pmid: 10508523
47. J. Gelineau-van Waes et al., Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation. Birth Defects Res. A Clin. Mol. Teratol. 82, 494 (2008). doi: 10.1002/bdra.20453; pmid: 18383508
48. J. Momb et al., Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc. Natl. Acad. Sci. U.S.A. 110, 549 (2013). doi: 10.1073/pnas.1211199110; pmid: 23267094
49. M. J. Harris, Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Birth Defects Res. A Clin. Mol. Teratol. 85, 331 (2009). doi: 10.1002/bdra.20552; pmid: 19117321
50. B. S. Mosley et al., Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am. J. Epidemiol. 169, 9 (2009). doi: 10.1093/aje/kwn331; pmid: 18953063
51. J. D. Gray et al., Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Hum. Mol. Genet. 19, 4560 (2010). doi: 10.1093/hmg/ddq384; pmid: 20843827
52. A. Marean, A. Graf, Y. Zhang, L. Niswander, Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival. Hum. Mol. Genet. 20, 3678 (2011). doi: 10.1093/hmg/ddr289; pmid: 21693562
53. E. B. Hook, A. E. Czeizel, Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet 350, 513 (1997). doi: 10.1016/S0140-6736(97)01342-1; pmid: 9274597
54. C. C. Y. Li et al., A sustained dietary change increases epigenetic variation in isogenic mice. PLoS Genet. 7, e1001380 (2011). doi: 10.1371/journal.pgen.1001380; pmid: 21541011
55. J. W. Hollingsworth et al., In utero supplementation with methyl donors enhances allergic airway disease in mice. J. Clin. Invest. 118, 3462 (2008). pmid: 18802477
56. M. J. Whitrow, V. M. Moore, A. R. Rumbold, M. J. Davies, Effect of supplemental folic acid in pregnancy on childhood asthma: A prospective birth cohort study. Am. J. Epidemiol. 170, 1486 (2009). doi: 10.1093/aje/kwp315; pmid: 19880541
57. F. J. H. Magdelijns, M. Mommers, J. Penders, L. Smits, C. Thijs, Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics 128, e135 (2011). doi: 10.1542/peds.2010-1690; pmid: 21690114
58. M. J. Harris, D. M. Juriloff, An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res. A Clin. Mol. Teratol. 88, 653 (2010). doi: 10.1002/bdra.20676; pmid: 20740593
59. D. M. Juriloff, M. J. Harris, Hypothesis: The female excess in cranial neural tube defects reflects an epigenetic drag of the inactivating X chromosome on the molecular mechanisms of neural fold elevation. Birth Defects Res. A Clin. Mol. Teratol. 94, 849 (2012). doi: 10.1002/bdra.23036; pmid: 22753363
60. C. Pyrgaki, P. Trainor, A.-K. Hadjantonakis, L. Niswander, Dynamic imaging of mammalian neural tube closure. Dev. Biol. 344, 941 (2010). doi: 10.1016/j.ydbio.2010.06.010; pmid: 20558153
61. J. B. Wallingford, R. M. Harland, Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development 129, 5815 (2002). doi: 10.1242/dev.00123; pmid: 12421719
62. H. Morita et al., Cell movements of the deep layer of non-neural ectoderm underlie complete neural tube closure in Xenopus. Development 139, 1417 (2012). doi: 10.1242/dev.073239; pmid: 22378637
63. H. W. Van Straaten, H. C. Janssen, M. C. Peeters, A. J. Copp, J. W. Hekking, Neural tube closure in the chick embryo is multiphasic. Dev. Dyn. 207, 309 (1996). doi: 10.1002/(SICI)1097-0177(199611)207:3〈309::AID-AJA8〉3. 0.CO;2-L; pmid: 8922530
64. H. W. Van Straaten, I. Sieben, J. W. Hekking, Multistep role for actin in initial closure of the mesencephalic neural groove in the chick embryo. Dev. Dyn. 224, 103 (2002). doi: 10.1002/dvdy.10078; pmid: 11984878
65. E. A. Jones et al., Dynamic in vivo imaging of postimplantation mammalian embryos using whole embryo culture. Genesis 34, 228 (2002). doi: 10.1002/gene.10162; pmid: 12434332
66. R. Massarwa, L. Niswander, In toto live imaging of mouse morphogenesis and new insights into neural tube closure. Development 140, 226 (2013). doi: 10.1242/dev.085001; pmid: 23175632
67. M. J. Harris, D. M. Juriloff, Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 79, 187 (2007). doi: 10.1002/bdra.20333; pmid: 17177317
68. J. D. Hildebrand, P. Soriano, Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99, 485 (1999). doi: 10.1016/S0092-8674(00)81537-8; pmid: 10589677
69. L. M. Lanier et al., Mena is required for neurulation and commissure formation. Neuron 22, 313 (1999). doi: 10.1016/S0896-6273(00)81092-2; pmid: 10069337
70. A. J. Koleske et al., Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259 (1998). doi: 10.1016/S0896-6273(00) 80646-7; pmid: 9883720
71. S. L. Haigo, J. D. Hildebrand, R. M. Harland, J. B. Wallingford, Shroom induces apical constriction and is required for hingepoint formation during neural tube closure. Curr. Biol. 13, 2125 (2003). doi: 10.1016/j.cub.2003.11. 054; pmid: 14680628
72. J. Roffers-Agarwal, J. B. Xanthos, K. A. Kragtorp, J. R. Miller, Enabled (Xena) regulates neural plate morphogenesis, apical constriction, and cellular adhesion required for neural tube closure in Xenopus. Dev. Biol. 314, 393 (2008). doi: 10.1016/j.ydbio.2007.12.010; pmid: 18201691
73. D. T. Fox, M. Peifer, Abelson kinase (Abl) and RhoGEF2 regulate actin organization during cell constriction in Drosophila. Development 134, 567 (2007). doi: 10.1242/dev.02748; pmid: 17202187
74. J. B. Wallingford, Planar cell polarity and the developmental control of cell behavior in vertebrate embryos. Annu. Rev. Cell Dev. Biol. 28, 627 (2012). doi: 10.1146/annurev-cellbio-092910-154208; pmid: 22905955
75. J. N. Murdoch, A. J. Copp, The relationship between sonic Hedgehog signaling, cilia, and neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 88, 633 (2010). doi: 10.1002/bdra.20686; pmid: 20544799
76. S. C. Goetz, K. V. Anderson, The primary cilium: A signalling centre during vertebrate development. Nat. Rev. Genet. 11, 331 (2010). doi: 10.1038/nrg2774; pmid: 20395968
77. D. Huangfu et al., Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 426, 83 (2003). doi: 10.1038/nature02061; pmid: 14603322
78. I. E. Zohn, K. V. Anderson, L. Niswander, Using genomewide mutagenesis screens to identify the genes required for neural tube closure in the mouse. Birth Defects Res. A Clin. Mol. Teratol. 73, 583 (2005). doi: 10.1002/bdra.20164; pmid: 15971254
79. P. Ybot-Gonzalez, P. Cogram, D. Gerrelli, A. J. Copp, Sonic hedgehog and the molecular regulation of mouse neural tube closure. Development 129, 2507 (2002). pmid: 11973281
80. E. C. Oh, N. Katsanis, Cilia in vertebrate development and disease. Development 139, 443 (2012). doi: 10.1242/dev.050054; pmid: 22223675
81. C. V. Logan, Z. Abdel-Hamed, C. A. Johnson, Molecular genetics and pathogenic mechanisms for the severe ciliopathies: Insights into neurodevelopment and pathogenesis of neural tube defects. Mol. Neurobiol. 43, 12 (2011). doi: 10.1007/s12035-010-8154-0; pmid: 21110233
82. T. W. Vogel, C. S. Carter, K. Abode-Iyamah, Q. Zhang, S. Robinson, The role of primary cilia in the pathophysiology of neural tube defects. Neurosurg. Focus 33, E2 (2012). doi: 10.3171/2012.6.FOCUS12222; pmid: 23025443
83. T. J. Park, S. L. Haigo, J. B. Wallingford, Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling. Nat. Genet. 38, 303 (2006). doi: 10.1038/ng1753; pmid: 16493421
84. R. S. Gray et al., The planar cell polarity effector Fuz is essential for targeted membrane trafficking, ciliogenesis and mouse embryonic development. Nat. Cell Biol. 11, 1225 (2009). doi: 10.1038/ncb1966; pmid: 19767740
85. J. H. Seo et al., Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum. Mol. Genet. 20, 4324 (2011). doi: 10.1093/hmg/ddr359; pmid: 21840926
86. Z. Kibar et al., Mutations in VANGL1 associated with neural-tube defects. N. Engl. J. Med. 356, 1432 (2007). doi: 10.1056/NEJMoa060651; pmid: 17409324
87. J. B. Wallingford, R. M. Harland, Xenopus Dishevelled signaling regulates both neural and mesodermal convergent extension: Parallel forces elongating the body axis. Development 128, 2581 (2001). pmid: 11493574
88. J. Wang et al., Dishevelled genes mediate a conserved mammalian PCP pathway to regulate convergent extension during neurulation. Development 133, 1767 (2006). doi: 10.1242/dev.02347; pmid: 16571627
89. P. Ybot-Gonzalez et al., Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure. Development 134, 789 (2007). doi: 10.1242/dev.000380; pmid: 17229766
90. M. Marin-Padilla, Study of the vertebral column in human craniorhachischisis. The significance of the notochordal alterations. Acta Anat. (Basel) 63, 32 (1966). doi: 10.1159/000142778; pmid: 5911674
91. I. Kirillova et al., Expression of the sonic hedgehog gene in human embryos with neural tube defects. Teratology 61, 347 (2000). doi: 10.1002/(SICI)1096-9926(200005)61:5〈347::AID-TERA6〉3.0.CO;2-#;pmid: 10777830
92. G. W. E. Santen et al., Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nat. Genet. 44, 379 (2012). doi: 10.1038/ng.2217; pmid: 22426309
93. Y. Tsurusaki et al., Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat. Genet. 44, 376 (2012). doi: 10.1038/ng.2219; pmid: 22426308
94. D. C. Hargreaves, G. R. Crabtree, ATP-dependent chromatin remodeling: Genetics, genomics and mechanisms. Cell Res. 21, 396 (2011). doi: 10.1038/cr.2011.32; pmid: 21358755
95. L. Wang et al., Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am. J. Clin. Nutr. 91, 1359 (2010). doi: 10.3945/ajcn.2009.28858; pmid: 20164316
96. N. D. Greene, A. J. Copp, Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3, 60 (1997). doi: 10.1038/nm0197-60; pmid: 8986742
97. J. G. Ray et al., Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 18, 362 (2007). doi: 10.1097/01.ede.0000257063.77411. e9; pmid: 17474166
98. A. C. Dey et al., Maternal and neonatal serum zinc level and its relationship with neural tube defects. J. Health Popul. Nutr. 28, 343 (2010). doi: 10.3329/jhpn.v28i4.6040; pmid: 20824977
99. M. Eiraku et al., Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472, 51 (2011). doi: 10.1038/nature09941; pmid: 21475194
100. H. Suga et al., Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480, 57 (2011). doi: 10.1038/nature10637; pmid: 22080957
101. P. W. Yoon et al., The National Birth Defects Prevention Study. Public Health Rep. 116 (suppl. 1), 32 (2001). doi: 10.1093/phr/116.S1.32; pmid: 11889273
102. C. Lee, H. M. Scherr, J. B. Wallingford, Shroom family proteins regulate gamma-tubulin distribution and microtubule architecture during epithelial cell shape change. Development 134, 1431 (2007). doi: 10.1242/dev.02828; pmid: 17329357